Armistice Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Armistice Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400,000	Closed	-$9.64M	–	293
2023 Q1	$9.64M	Buy	+400,000	New	+$5.02M	0.14%	90

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Armistice Capital's PRVB Position: Q2 2023 in Review

Armistice Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 400,000 shares — an estimated $9.64M sold.

Armistice Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $9.64M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Armistice Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Armistice Capital sold 400,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $9.64M.
Armistice Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Armistice Capital's Provention Bio, Inc. Common Stock position peaked at $9.64M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.